应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SPRO Spero Therapeutics Inc.
盘后交易 06-16 18:05:09 EDT
2.85
+0.02
+0.71%
盘后
2.85
+0.00
0.00%
17:28 EDT
最高
2.95
最低
2.83
成交量
110.71万
今开
2.84
昨收
2.83
日振幅
4.24%
总市值
1.59亿
流通市值
1.19亿
总股本
5,591万
成交额
318.63万
换手率
2.65%
流通股本
4,173万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Spero Therapeutics盘初飙涨228%
国际金融报 · 05-28
Spero Therapeutics盘初飙涨228%
美股异动 | 盘前飙涨225%!Spero Therapeutics(SPRO.US)尿路感染药物3期试验取得成功
智通财经 · 05-28
美股异动 | 盘前飙涨225%!Spero Therapeutics(SPRO.US)尿路感染药物3期试验取得成功
Spero Therapeutics, Inc.2025财年第一财季实现净利润-13.87百万美元,同比减少9.47%
市场透视 · 05-19
Spero Therapeutics, Inc.2025财年第一财季实现净利润-13.87百万美元,同比减少9.47%
Spero Therapeutics, Inc.盘中异动 股价大涨5.66%
市场透视 · 05-16
Spero Therapeutics, Inc.盘中异动 股价大涨5.66%
Spero Therapeutics, Inc.盘中异动 股价大跌5.80%报0.650美元
市场透视 · 05-14
Spero Therapeutics, Inc.盘中异动 股价大跌5.80%报0.650美元
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.72%报0.608美元
市场透视 · 05-09
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.72%报0.608美元
Spero Therapeutics, Inc.盘中异动 下午盘股价大涨5.36%报0.609美元
市场透视 · 05-09
Spero Therapeutics, Inc.盘中异动 下午盘股价大涨5.36%报0.609美元
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.07%
市场透视 · 05-06
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.07%
Spero Therapeutics, Inc.盘中异动 急速下挫5.72%报0.610美元
市场透视 · 05-06
Spero Therapeutics, Inc.盘中异动 急速下挫5.72%报0.610美元
Spero Therapeutics, Inc.盘中异动 下午盘大幅下挫5.49%报0.671美元
市场透视 · 04-30
Spero Therapeutics, Inc.盘中异动 下午盘大幅下挫5.49%报0.671美元
Spero Therapeutics, Inc.盘中异动 早盘快速上涨5.12%
市场透视 · 04-22
Spero Therapeutics, Inc.盘中异动 早盘快速上涨5.12%
Spero Therapeutics, Inc.盘中异动 股价大涨5.07%报0.778美元
市场透视 · 04-17
Spero Therapeutics, Inc.盘中异动 股价大涨5.07%报0.778美元
Spero Therapeutics, Inc.盘中异动 早盘急速拉升6.99%报0.750美元
市场透视 · 04-15
Spero Therapeutics, Inc.盘中异动 早盘急速拉升6.99%报0.750美元
Spero Therapeutics, Inc.盘中异动 股价大涨5.81%报0.821美元
市场透视 · 03-03
Spero Therapeutics, Inc.盘中异动 股价大涨5.81%报0.821美元
Spero Therapeutics, Inc.盘中异动 早盘股价大跌6.03%
市场透视 · 02-25
Spero Therapeutics, Inc.盘中异动 早盘股价大跌6.03%
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报0.839美元
市场透视 · 02-11
Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报0.839美元
Spero Therapeutics, Inc.盘中异动 快速跳水5.02%报0.820美元
市场透视 · 02-08
Spero Therapeutics, Inc.盘中异动 快速跳水5.02%报0.820美元
Spero Therapeutics, Inc.盘中异动 下午盘股价大跌5.97%
市场透视 · 02-05
Spero Therapeutics, Inc.盘中异动 下午盘股价大跌5.97%
Spero Therapeutics, Inc.盘中异动 股价大跌5.44%报0.810美元
市场透视 · 02-03
Spero Therapeutics, Inc.盘中异动 股价大跌5.44%报0.810美元
Spero Therapeutics, Inc.盘中异动 股价大涨5.26%报0.920美元
市场透视 · 01-23
Spero Therapeutics, Inc.盘中异动 股价大涨5.26%报0.920美元
加载更多
公司概况
公司名称:
Spero Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,该公司相信这将开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。该公司相信,如果成功地开发和批准该新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。
发行价格:
--
{"stockData":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":2.85,"timestamp":1750104000000,"preClose":2.83,"halted":0,"volume":1107122,"hourTrading":{"tag":"盘后","latestPrice":2.85,"preClose":2.85,"latestTime":"17:28 EDT","volume":1988,"amount":5661.566156399999,"timestamp":1750109308146},"delay":0,"floatShares":41728895,"shares":55910641,"eps":-1.281173,"marketStatus":"盘后交易","change":0.02,"latestTime":"06-16 18:05:09 EDT","open":2.84,"high":2.95,"low":2.83,"amount":3186273.0914526,"amplitude":0.042403,"askPrice":2.92,"askSize":5,"bidPrice":2.83,"bidSize":318,"shortable":3,"etf":0,"ttmEps":-1.281173,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1509595200000,"exchange":"NASDAQ","adjPreClose":2.83,"dividendRate":0.000351,"preHourTrading":{"tag":"盘前","latestPrice":2.84,"preClose":2.83,"latestTime":"09:29 EDT","volume":34009,"amount":96876.35735539999,"timestamp":1750080570039},"postHourTrading":{"tag":"盘后","latestPrice":2.85,"preClose":2.85,"latestTime":"17:28 EDT","volume":1988,"amount":5661.566156399999,"timestamp":1750109308146},"volumeRatio":0.449354,"impliedVol":1.213,"impliedVolPercentile":0.368},"requestUrl":"/m/hq/s/SPRO","defaultTab":"news","newsList":[{"id":"2538547170","title":"Spero Therapeutics盘初飙涨228%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538547170","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538547170?lang=zh_cn&edition=full","pubTime":"2025-05-28 21:39","pubTimestamp":1748439545,"startTime":"0","endTime":"0","summary":"Spero Therapeutics盘初飙涨228%,尿路感染药物3期试验取得成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528213912a6f07558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528213912a6f07558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","SPRO","BK4539","BK4139"],"gpt_icon":0},{"id":"2538428479","title":"美股异动 | 盘前飙涨225%!Spero Therapeutics(SPRO.US)尿路感染药物3期试验取得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2538428479","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538428479?lang=zh_cn&edition=full","pubTime":"2025-05-28 21:08","pubTimestamp":1748437705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周三美股盘前交易中,Spero Therapeutics股价飙升近225%。此前该公司及其合作伙伴葛兰素史克宣布,他们用于治疗尿路感染的口服药物 tebipenem HBr在一项关键的 3 期临床试验中达到了主要目标。名为“PIVOT-PO”的这项研究旨在对tebipenem HBr与静脉注射亚胺培南-西司他丁进行评估,研究对象为超过 1600 名因复杂性尿路感染而住院的成年人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","BK4007","SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2536594844","title":"Spero Therapeutics, Inc.2025财年第一财季实现净利润-13.87百万美元,同比减少9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594844","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594844?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584105,"startTime":"0","endTime":"0","summary":"5月19日,Spero Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-13.87百万美元,同比减少9.47%;其中营业收入为5.11百万美元,同比增加21.67%,每股基本收益为-0.25美元。机构评级:截至2025年5月19日,当前有1家机构对Spero Therapeutics, Inc.目标价做出预测,其中目标均价为5.00美元,其中最低目标价为5.00美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000645a6e3a8b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000645a6e3a8b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2535875526","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535875526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535875526?lang=zh_cn&edition=full","pubTime":"2025-05-16 00:20","pubTimestamp":1747326000,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日00时20分,Spero Therapeutics, Inc.股票出现波动,股价大幅上涨5.66%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。其相关个股中,Nucana Plc、Renovaro Inc.、Scpharmaceuticals Inc.涨幅较大,Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃,换手率分别为12106.73%、4575.25%、305.76%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Briacell Therapeutics Corp C/Wts 26/02/2026,振幅分别为76.92%、63.87%、60.27%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516002000a6e092e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516002000a6e092e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SPRO","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2535502075","title":"Spero Therapeutics, Inc.盘中异动 股价大跌5.80%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535502075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535502075?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:09","pubTimestamp":1747231755,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时09分,Spero Therapeutics, Inc.股票出现异动,股价急速下跌5.80%。截至发稿,该股报0.650美元/股,成交量1.8677万股,换手率0.03%,振幅5.80%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Klotho Neurosciences, Inc.、Septerna, Inc.、蓝鸟生物涨幅较大,Nucana Plc、Polyrizon Ltd.、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为3011.24%、2269.52%、1413.27%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Rani Therapeutics Holdings, Inc.,振幅分别为59.77%、46.33%、42.54%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514220916a6df11bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514220916a6df11bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2534480789","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.72%报0.608美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480789?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:42","pubTimestamp":1746798145,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时42分,Spero Therapeutics, Inc.股票出现波动,股价急速拉升5.72%。截至发稿,该股报0.608美元/股,成交量2.958万股,换手率0.05%,振幅3.50%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。其相关个股中,Osr Holdings Inc C/Wts 09/02/2028 、Celularity Inc C/Wts 16/07/2026 、艾切托涨幅较大,Nucana Plc、Polyrizon Ltd.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为515.76%、123.28%、12.52%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Phathom Pharmaceuticals, Inc.、Protalix Biotherapeutics, Inc. ,振幅分别为76.90%、22.71%、17.65%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921422694f1d75c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050921422694f1d75c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","SPRO","BK4539","LENZ"],"gpt_icon":0},{"id":"2534476168","title":"Spero Therapeutics, Inc.盘中异动 下午盘股价大涨5.36%报0.609美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534476168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534476168?lang=zh_cn&edition=full","pubTime":"2025-05-09 02:57","pubTimestamp":1746730621,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日02时57分,Spero Therapeutics, Inc.股票出现波动,股价快速上涨5.36%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.15%。其相关个股中,Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大,Nucana Plc、Gri Bio, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为655.87%、120.74%、110.23%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为92.50%、81.08%、59.60%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509025701975386ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509025701975386ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","SPRO"],"gpt_icon":0},{"id":"2533637189","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533637189?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:35","pubTimestamp":1746538506,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时35分,Spero Therapeutics, Inc.股票出现异动,股价大幅拉升5.07%。截至发稿,该股报0.641美元/股,成交量1.3525万股,换手率0.02%,振幅0.00%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.27%。其相关个股中,Pasithea Therapeutics Corp.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Heron Therapeutics, Inc.涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为1624.05%、835.20%、213.02%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Briacell Therapeutics Corp C/Wts 26/02/2026、Renovaro Inc.,振幅分别为26.76%、22.46%、12.75%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621350694ee0e89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050621350694ee0e89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139","BK4007"],"gpt_icon":0},{"id":"2533599565","title":"Spero Therapeutics, Inc.盘中异动 急速下挫5.72%报0.610美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533599565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533599565?lang=zh_cn&edition=full","pubTime":"2025-05-06 01:58","pubTimestamp":1746467925,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日01时58分,Spero Therapeutics, Inc.股票出现异动,股价快速下挫5.72%。截至发稿,该股报0.610美元/股,成交量7.3471万股,换手率0.13%,振幅8.18%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Nucana Plc、Scisparc Ltd.、Polyrizon Ltd.较为活跃,换手率分别为1151.36%、739.02%、93.38%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nucana Plc,振幅分别为156.25%、113.27%、72.23%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506015845aa2c8363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506015845aa2c8363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","SPRO","BK4139"],"gpt_icon":0},{"id":"2531938947","title":"Spero Therapeutics, Inc.盘中异动 下午盘大幅下挫5.49%报0.671美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531938947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531938947?lang=zh_cn&edition=full","pubTime":"2025-04-30 02:49","pubTimestamp":1745952572,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日02时49分,Spero Therapeutics, Inc.股票出现异动,股价大幅下跌5.49%。截至发稿,该股报0.671美元/股,成交量4.3459万股,换手率0.08%,振幅5.20%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Cyclacel Pharmaceuticals, Inc.、Kala Bio, Inc.、Inflarx N.V.涨幅较大,Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃,换手率分别为172.32%、160.99%、139.66%,振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为134.52%、54.29%、50.68%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430024932aa2c7e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430024932aa2c7e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2529353875","title":"Spero Therapeutics, Inc.盘中异动 早盘快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529353875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529353875?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:46","pubTimestamp":1745329608,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时46分,Spero Therapeutics, Inc.股票出现异动,股价快速上涨5.12%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.27%。其相关个股中,Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为176.59%、95.43%、55.55%,振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Ibio, Inc.,振幅分别为30.03%、23.53%、21.80%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214649aa2c7618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214649aa2c7618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2528741045","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.07%报0.778美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528741045?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:18","pubTimestamp":1744899515,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时18分,Spero Therapeutics, Inc.股票出现波动,股价大幅上涨5.07%。截至发稿,该股报0.778美元/股,成交量4312股,换手率0.01%,振幅3.69%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Channel Therapeutics Corporation、Uniqure N.V.、Radiopharm Theranostics Limited涨幅较大,Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为530.48%、159.70%、105.16%,振幅较大的相关个股有Channel Therapeutics Corporation、Processa Pharmaceuticals, Inc.、Kazia Therapeutics Limited,振幅分别为43.82%、43.27%、29.38%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417221836aa2c7322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417221836aa2c7322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","BK4007","LENZ"],"gpt_icon":0},{"id":"2527141774","title":"Spero Therapeutics, Inc.盘中异动 早盘急速拉升6.99%报0.750美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527141774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527141774?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:49","pubTimestamp":1744724942,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时49分,Spero Therapeutics, Inc.股票出现波动,股价急速拉升6.99%。截至发稿,该股报0.750美元/股,成交量8909股,换手率0.02%,振幅4.28%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Mural Oncology Plc、Verve Therapeutics, Inc.、Prokidney Corp.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为583.35%、215.26%、85.78%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc、Nextcure, Inc.,振幅分别为80.08%、66.02%、38.78%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214902a459ca5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214902a459ca5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO","BK4007"],"gpt_icon":0},{"id":"2516323416","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.81%报0.821美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516323416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516323416?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012558,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分,Spero Therapeutics, Inc.股票出现异动,股价大幅拉升5.81%。截至发稿,该股报0.821美元/股,成交量1.3081万股,换手率0.02%,振幅1.93%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。其相关个股中,Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为48.17%、32.30%、29.61%,振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.,振幅分别为21.22%、19.25%、16.66%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223558abe634c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223558abe634c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2514775240","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775240?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:23","pubTimestamp":1740414181,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时23分,Spero Therapeutics, Inc.股票出现异动,股价大幅下跌6.03%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为244.73%、110.91%、34.18%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Celularity Inc C/Wts 16/07/2026 ,振幅分别为162.04%、55.69%、54.86%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002301962eb1cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002301962eb1cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2510380652","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报0.839美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380652?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:41","pubTimestamp":1739284897,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时41分,Spero Therapeutics, Inc.股票出现波动,股价快速拉升5.47%。截至发稿,该股报0.839美元/股,成交量3769股,换手率0.01%,振幅1.13%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.30%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2246.85%、594.59%、232.24%,振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.,振幅分别为33.04%、31.80%、29.38%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241389881bf0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241389881bf0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2509974729","title":"Spero Therapeutics, Inc.盘中异动 快速跳水5.02%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509974729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509974729?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:55","pubTimestamp":1738947300,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时55分,Spero Therapeutics, Inc.股票出现异动,股价急速跳水5.02%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.58%。其相关个股中,Conduit Pharmaceuticals Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为5352.11%、168.60%、102.84%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为130.43%、67.10%、53.38%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005501987dc70d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005501987dc70d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2509412496","title":"Spero Therapeutics, Inc.盘中异动 下午盘股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509412496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509412496?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:25","pubTimestamp":1738700748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时25分,Spero Therapeutics, Inc.股票出现波动,股价快速下跌5.97%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.28%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Mink Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1952.22%、989.90%、587.97%,振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.,振幅分别为123.99%、59.42%、58.27%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042549987a802a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042549987a802a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2508914184","title":"Spero Therapeutics, Inc.盘中异动 股价大跌5.44%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508914184?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:47","pubTimestamp":1738594055,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时47分,Spero Therapeutics, Inc.股票出现波动,股价大幅跳水5.44%。截至发稿,该股报0.810美元/股,成交量3.0259万股,换手率0.06%,振幅1.82%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为416.32%、352.70%、216.64%,振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.,振幅分别为82.67%、50.76%、35.62%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224735abc10b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224735abc10b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2505527014","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.26%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505527014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505527014?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:42","pubTimestamp":1737643377,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时42分,Spero Therapeutics, Inc.股票出现波动,股价大幅拉升5.26%。截至发稿,该股报0.920美元/股,成交量2162股,换手率0.00%,振幅0.00%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Hepion Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Exicure, Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃,换手率分别为2213.85%、518.29%、40.11%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 、Exicure, Inc.,振幅分别为54.22%、49.73%、29.32%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123224258abb5fd66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123224258abb5fd66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sperotherapeutics.com","stockEarnings":[{"period":"1week","weight":0.132},{"period":"1month","weight":3.3532},{"period":"3month","weight":2.6171},{"period":"6month","weight":1.6449},{"period":"1year","weight":1.0657},{"period":"ytd","weight":1.7476}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":0.016},{"period":"3month","weight":0.0607},{"period":"6month","weight":-0.0119},{"period":"1year","weight":0.1006},{"period":"ytd","weight":0.0186}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,该公司相信这将开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。该公司相信,如果成功地开发和批准该新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038583},{"month":2,"riseRate":0.5,"avgChangeRate":-0.045634},{"month":3,"riseRate":0.375,"avgChangeRate":-0.006715},{"month":4,"riseRate":0.25,"avgChangeRate":-0.035686},{"month":5,"riseRate":0.375,"avgChangeRate":0.239464},{"month":6,"riseRate":0.5,"avgChangeRate":0.002148},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.042117},{"month":8,"riseRate":0.285714,"avgChangeRate":0.04487},{"month":9,"riseRate":0.428571,"avgChangeRate":0.176126},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.040426},{"month":11,"riseRate":0.571429,"avgChangeRate":0.022543},{"month":12,"riseRate":0.375,"avgChangeRate":-0.010317}],"exchange":"NASDAQ","name":"Spero Therapeutics Inc.","nameEN":"Spero Therapeutics Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.0","shortVersion":"4.34.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spero Therapeutics Inc.,SPRO,Spero Therapeutics Inc.股票,Spero Therapeutics Inc.股票老虎,Spero Therapeutics Inc.股票老虎国际,Spero Therapeutics Inc.行情,Spero Therapeutics Inc.股票行情,Spero Therapeutics Inc.股价,Spero Therapeutics Inc.股市,Spero Therapeutics Inc.股票价格,Spero Therapeutics Inc.股票交易,Spero Therapeutics Inc.股票购买,Spero Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}